Research Article
A Small Disc Area Is a Risk Factor for Visual Field Loss Progression in Primary Open-Angle Glaucoma: The Glaucoma Stereo Analysis Study
Table 1
Comparison of demographic data between patients in the progression and no-progression groups.
| | Patient data | Progression () | No progression () | Value |
| | Age (years) | 61.48 ± 8.92 | 61.33 ± 9.58 | 0.92 | | Sex (male : female) | 25 : 25 | 62 : 75 | 0.62 | | Hypertension (+) | 7 (14%) | 41 (29.93%) | 0.037 | | Corneal curvature radius on the test day (mm) | 7.65 ± 0.25 | 7.68 ± 0.28 | 0.52 | | Pretreatment IOP (mmHg) | 16.97 ± 4.87 | 16.92 ± 4.09 | 0.94 | | PG (+) | 35 (70%) | 93 (67.88%) | 0.86 | | β-Blocker (+) | 28 (56%) | 51 (37.23%) | 0.029 | | CAI (+) | 16 (32%) | 16 (11.68%) | 0.002 | | Antiglaucoma eyedrops (number) | 1.70 ± 1.04 | 1.20 ± 0.88 | 0.0012 | | MD (dB) | −5.88 ± 2.91 | −4.28 ± 3.28 | 0.0028 | | PSD (dB) | 9.43 ± 3.69 | 7.59 ± 4.25 | 0.0074 | | Pretreatment spherical equivalent refractive error (D) | −3.49 ± 3.89 | −3.34 ± 3.72 | 0.8 | | MD slope (dB/year) | −0.58 ± 0.28 | 0.05 ± 0.26 | <0.0001 |
|
|
PG = prostaglandin; CAI = carbonic anhydrase inhibitor; MD = mean deviation; PSD = pattern standard deviation.
|
